AC
PAVM icon

Ayrton Capital’s PAVmed PAVM Stock Holding History

Ayrton Capital’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$661K Buy
4,987
+3,988
+399% +$618K 4.48% 8
2023
Q2 		$183K Buy
999
+43
+4% +$8.6K 1.14% 15
2023
Q1 		$161K Buy
+956
New +$201K 0.58% 23
2022
Q4 		– Sell
-3,555
Closed -$1.38M – 102
2022
Q3 		$1.38M Buy
+3,555
New +$2.01M 2.41% 15

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Ayrton Capital's PAVM Position: Q3 2023 in Review

Ayrton Capital increased its PAVmed (PAVM) stake by 399% in Q3 2023, buying an estimated $618K and bringing the position to 4,987 shares worth $661K. The position accounts for 4.48% of the portfolio, ranked #8.

Ayrton Capital first reported a position in PAVM in Q3 2022 and has held it in 4 quarters since. The position peaked at $1.38M in Q3 2022. 60 funds tracked by Wall St. Rank hold PAVM as of Q3 2023.

  • Ayrton Capital held 4,987 shares of PAVmed worth $661K as of Q3 2023.
  • Ayrton Capital bought 3,988 PAVmed shares in Q3 2023, an estimated $618K.
  • PAVmed made up 4.48% of Ayrton Capital's portfolio in Q3 2023, its #8 holding.
  • Ayrton Capital first reported a position in PAVmed in Q3 2022 and has held it in 4 quarters since.
  • Ayrton Capital's PAVmed position peaked at $1.38M in Q3 2022.
  • 60 funds tracked by Wall St. Rank held PAVmed as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.